Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Amar H Kelkar

Showing results (1-10 of 65) with videos related to

Pageof 7
Sort By:
The New England Journal of Medicine|May 7, 2025
U.S. Research Leadership at a Crossroads - The Impact of Reducing NIH Indirect-Cost CoverageAmar H Kelkar
Hematology. American Society of Hematology. Education Program|December 4, 2020
Do prophylactic inferior vena cava filters in trauma patients reduce the risk of mortality or pulmonary embolism?Amar H Kelkar, Anita Rajasekhar
Cureus|March 31, 2021
Undiagnosed Wilson's Disease and Fibromyalgia Masking Bowel PerforationTyler Culpepper, Amar H Kelkar
Hematology. American Society of Hematology. Education Program|December 4, 2020
Inferior vena cava filters: a framework for evidence-based useAmar H Kelkar, Anita Rajasekhar
Healthcare (Basel, Switzerland)|July 26, 2020
Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of CareAmar H Kelkar, Christopher R Cogle
Blood|January 2, 2025
Decoding cost-effectiveness of PNH therapiesAmar H Kelkar, Gregory A Abel
JAMA Neurology|October 3, 2022
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease-Estimating the True ValueEdward R Scheffer Cliff, Amar H Kelkar
JAMA|July 28, 2025
Reducing Drug Prices-The Most Favored Nation Policy vs Price NegotiationAmar H Kelkar, Edward R Scheffer Cliff
Blood Advances|April 24, 2025
An Ethical Allocation Scheme for Scarce Gene Therapies in Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaAmar H Kelkar, Maureen O Achebe, Andrew Hantel
Cureus|May 26, 2021
Diffuse Large B-Cell Lymphoma Presenting as an Unusual Paraneoplastic Neurologic Syndrome Affecting the Central and Peripheral Nervous SystemsAnthony D Sorrentino, Amar H Kelkar, Nam H Dang
Pageof 7

Showing results (1-10 of 65) with videos related to

Sort By:
Pageof 7
The New England Journal of Medicine|May 7, 2025
U.S. Research Leadership at a Crossroads - The Impact of Reducing NIH Indirect-Cost CoverageAmar H Kelkar
Hematology. American Society of Hematology. Education Program|December 4, 2020
Do prophylactic inferior vena cava filters in trauma patients reduce the risk of mortality or pulmonary embolism?Amar H Kelkar, Anita Rajasekhar
Cureus|March 31, 2021
Undiagnosed Wilson's Disease and Fibromyalgia Masking Bowel PerforationTyler Culpepper, Amar H Kelkar
Hematology. American Society of Hematology. Education Program|December 4, 2020
Inferior vena cava filters: a framework for evidence-based useAmar H Kelkar, Anita Rajasekhar
Healthcare (Basel, Switzerland)|July 26, 2020
Cancer in the Time of Coronavirus: A Call for Crisis Oncology Standards of CareAmar H Kelkar, Christopher R Cogle
Blood|January 2, 2025
Decoding cost-effectiveness of PNH therapiesAmar H Kelkar, Gregory A Abel
JAMA Neurology|October 3, 2022
Cost-effectiveness of Aducanumab and Donanemab for Early Alzheimer Disease-Estimating the True ValueEdward R Scheffer Cliff, Amar H Kelkar
JAMA|July 28, 2025
Reducing Drug Prices-The Most Favored Nation Policy vs Price NegotiationAmar H Kelkar, Edward R Scheffer Cliff
Blood Advances|April 24, 2025
An Ethical Allocation Scheme for Scarce Gene Therapies in Sickle Cell Disease and Transfusion-Dependent β-ThalassemiaAmar H Kelkar, Maureen O Achebe, Andrew Hantel
Cureus|May 26, 2021
Diffuse Large B-Cell Lymphoma Presenting as an Unusual Paraneoplastic Neurologic Syndrome Affecting the Central and Peripheral Nervous SystemsAnthony D Sorrentino, Amar H Kelkar, Nam H Dang
Pageof 7